Herbal medicines – they are popular, but are they also safe? Edzard Ernst Editorial 10 December 2005 Pages: 1 - 2
Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome Amr El-HusseiniFathy El-BasuonyMohamed Sobh Clinical Trials 23 December 2005 Pages: 3 - 8
Effect of pravastatin on plasma sterols and oxysterols in men Karin M. ThelenDieter LütjohannReijo Laaksonen Clinical Trials 30 December 2005 Pages: 9 - 14
Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology Paula M. FerreiraRaquel CatarinoRui Medeiros Pharmacogenetics 22 December 2005 Pages: 15 - 21
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy Keiji TakataJunji SaruwatariKazuko Nakagawa Pharmacogenetics 30 December 2005 Pages: 23 - 28
The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose Silke C. MuellerJolanta Majcher-PeszynskaBernd Drewelow Pharmacokinetics and Disposition 10 December 2005 Pages: 29 - 36
Safety implications regarding use of phytomedicines Laura CuzzolinSilvana ZaffaniGiuseppina Benoni Pharmacoepidemiology and Prescription 03 December 2005 Pages: 37 - 42
Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction Lars BjerrumMorten AndersenJesper Hallas Pharmacoepidemiology and Prescription 06 December 2005 Pages: 43 - 49
The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands Tjalling W. de VriesHilde TobiLolkje T. W. de Jong-van den Berg Pharmacoepidemiology and Prescription 20 December 2005 Pages: 51 - 55
Improving the performance of Drug and Therapeutics Committees in hospitals – a quasi-experimental study in Laos Chu VangGoran TomsonRolf Wahlstrom Pharmacoepidemiology and Prescription 22 December 2005 Pages: 57 - 63
Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms Alberto PilottoMarilisa FranceschiF.I.R.I. (Fondazione Italiana Ricerca Invecchiamento) and the SOFIA Project Investigators Pharmacoepidemiology and Prescription 30 December 2005 Pages: 65 - 73
CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response Ondřej SlanařMilan NobilisFrantišek Perlík Letter to the Editors 08 November 2005 Pages: 75 - 76
Impact of the CYP2D6 metaboliser status on the pupillary response of tramadol—a commentary Frank FliegertBurkhard KurthKarin Göhler Letter to the Editor 03 December 2005 Pages: 77 - 78
Response to Naunton and Duyvendak re “Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?” Lara MonesiFausto AvanziniMaria Carla Roncaglioni Letter to the Editor 01 December 2005 Pages: 79 - 80
Underuse of antiplatelets and inappropriate use Mark NauntonMichiel Duyvendak Letter to the Editors 01 December 2005 Pages: 81 - 82
Evaluation of the effect of multiple-dose administration of R411, a dual α4β1–α4β7 integrin antagonist on the major CYP isoform activities in healthy volunteers Youssef HijaziHorst WelkerIndravadan Patel Letter to the Editors 21 December 2005 Pages: 83 - 85
Treatment of chorea with levetiracetam Theresa A. ZesiewiczAmit PathakRobert A. Hauser Letter to the Editor 01 December 2005 Pages: 87 - 87